Rodrigo Dienstmann

机构：Universitat de Vic - Universitat Central de Catalunya, Hebron University, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology · ORCID：0000-0001-5997-318X

发表论文 694 篇 · 总被引 21969 次 · h-index 60

代表论文

• TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching (2026 · Nature Communications · 被引 10)
• Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy (2025 · Clinical Cancer Research · 被引 7)
• The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6 (2025 · Breast Cancer Research and Treatment · 被引 5)
• Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial (2025 · ESMO Open · 被引 4)
• AI assistance in tumor multidisciplinary teams (2026 · ESMO Real World Data and Digital Oncology · 被引 3)
• Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors (2025 · ESMO Open · 被引 3)